IRIS
SCUTERI, DAMIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 941
NA - Nord America 893
EU - Europa 416
SA - Sud America 235
AF - Africa 12
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 2.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 856
SG - Singapore 475
CN - Cina 218
IT - Italia 205
BR - Brasile 192
IN - India 102
VN - Vietnam 81
GB - Regno Unito 49
DE - Germania 39
CA - Canada 24
FI - Finlandia 22
SE - Svezia 21
EC - Ecuador 15
HK - Hong Kong 12
RU - Federazione Russa 12
AR - Argentina 11
IQ - Iraq 10
NL - Olanda 10
EE - Estonia 9
MX - Messico 9
PL - Polonia 9
BD - Bangladesh 8
AT - Austria 7
TR - Turchia 7
ZA - Sudafrica 7
AU - Australia 6
FR - Francia 6
NZ - Nuova Zelanda 6
PE - Perù 6
ES - Italia 5
IE - Irlanda 5
TW - Taiwan 5
UA - Ucraina 5
CL - Cile 4
EU - Europa 4
JP - Giappone 4
RO - Romania 4
CO - Colombia 3
ID - Indonesia 3
PK - Pakistan 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
HR - Croazia 2
JO - Giordania 2
MA - Marocco 2
PY - Paraguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 2.516
Salva come PNG Salva come JPEG
Città #
Dallas 170
Singapore 158
Santa Clara 92
Bengaluru 88
Hefei 88
Ashburn 59
Chandler 48
Beijing 41
Lawrence 38
Princeton 38
Ho Chi Minh City 37
Milan 35
Chicago 33
London 32
Wilmington 22
Catanzaro 19
São Paulo 19
Hanoi 18
Los Angeles 18
Munich 18
Helsinki 15
Hong Kong 12
Redwood City 12
Des Moines 11
New York 11
Warsaw 9
Ann Arbor 8
Birmingham 8
Ottawa 7
Palermo 7
Rome 7
Turku 7
Vallefiorita 7
Brooklyn 6
Florence 6
Lima 6
Shenzhen 6
Amsterdam 5
Boardman 5
Boston 5
Chennai 5
Montreal 5
Phoenix 5
Quito 5
Rio de Janeiro 5
San Francisco 5
St Petersburg 5
Washington 5
Assago 4
Atlanta 4
Auckland 4
Charlotte 4
Guangzhou 4
Johannesburg 4
Manchester 4
Naples 4
Palizzi Marina 4
San Ferdinando 4
Shanghai 4
Stockholm 4
Taipei 4
The Dalles 4
Tokyo 4
Ankara 3
Aversa 3
Baghdad 3
Bologna 3
Brasília 3
Council Bluffs 3
Curitiba 3
Dublin 3
García 3
Hackney 3
Haiphong 3
Horia 3
Itaquaquecetuba 3
Mumbai 3
Rende 3
Riobamba 3
Rizziconi 3
Salvador 3
San Nicola Manfredi 3
Springfield 3
Thái Nguyên 3
Toronto 3
Viamão 3
Wuhan 3
Amman 2
Asunción 2
Bangkok 2
Barquisimeto 2
Bogotá 2
Buccinasco 2
Buenos Aires 2
Campinas 2
Can Tho 2
Carapicuíba 2
Carolei 2
Catania 2
Columbus 2
Totale 1.429
Salva come PNG Salva come JPEG
Nome #
Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs 74
Benefits and risks associated with cannabis and cannabis derivatives use 72
Pharmacoutilization data-driven artificial intelligence–assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 63
Pain assessment and treatment in dementia at the time of coronavirus disease covid-19 56
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats. 55
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 54
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial 53
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs. 50
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies. 49
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 48
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach. 47
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 47
Impact of nutraceuticals on glaucoma: A systematic review 43
Benefits and risks associated with cannabis and cannabis derivatives use 43
Focus on zavegepant: the first intranasal third-generation gepant 42
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 42
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 41
Aging brain: In search for better neurotherapeutics 40
Evidence on the neuroprotective properties of brimonidine in glaucoma 40
New trends in pain research: from basic research to clinical translation 39
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 38
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms 36
Pattern of triptans use: A retrospective prescription study in Calabria, Italy 36
Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol 35
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats 35
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 33
Proposal of combination therapies to treat refractory chronic migraine 33
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 33
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia 32
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 31
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 31
The need for better access to pain treatment: learning from drug consumption trends in the USA. 31
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 30
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 30
Eptinezumab for the treatment of migraine 30
Development and translation of nanobeo, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia 30
Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 29
Basic, Translational, and Clinical Research on Dementia 28
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice 28
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 28
New trends in pharmacological control of neuropsychiatric symptoms of dementia 28
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 28
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 28
Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8 27
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 27
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 27
Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance 27
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 25
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 25
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 25
Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation” 25
Aromatherapy in Stroke Patients: Is it Time to Begin? 24
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 24
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy 24
Efficacy of essential oils in pain: A systematic review and meta-analysis of preclinical evidence 24
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy 24
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 23
Aging Brain: In Search of Better Neurotherapeutics 23
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 23
Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia 23
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation 22
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing 22
Real world considerations for newly approved CGRP receptor antagonists in migraine care 21
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 21
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy. 21
Exploitation of thermal sensitivity and hyperalgesia in a mouse model of dystonia 21
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 20
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 20
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 19
Dementia therapeutics and cognitive rehabilitation 19
Opioids Resistance in Chronic Pain Management 19
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol 19
Unbiased research is needed for rational translation of essential oils in clinic 19
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 19
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats 19
Essential oils-induced analgesia and related translation for the management of agitation in dementia 18
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP 18
Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia 18
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 18
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 17
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 17
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65 17
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis 16
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 15
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 14
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 13
Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review 12
Epigenetic and nanotechnology alliance to fight stroke-induced brain damage 10
Totale 2.643
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 8 7 0 5 7 0 0 1
2021/2022122 4 1 2 13 5 22 9 21 6 15 23 1
2022/2023229 78 9 7 9 17 30 6 21 23 8 17 4
2023/2024194 44 18 14 10 14 45 7 6 4 5 24 3
2024/2025908 125 58 35 21 87 104 20 18 157 44 82 157
2025/20261.065 86 314 198 280 187 0 0 0 0 0 0 0
Totale 2.643